ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Buspirone Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-0W8602
Home | Market Reports | Health| Mental Health| Anxiety & Stress
Global Buspirone Market Insights Forecast to 2028
BUY CHAPTERS

Global Buspirone Market Research Report 2025

Code: QYRE-Auto-0W8602
Report
July 2025
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Bristol–Myers Squibb
Apotex
Dr. Reddy’s Laboratories
Laboratoires Servier
TEVA
AMAG Pharmaceuticals
Mylan NV
Novartis
Watson Laboratories
Hikma
WOCKHARDT
Cadila Healthcare
Orion Corporation

Buspirone Market

The global market for Buspirone was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Buspirone, sold under the brand name Buspar among others, is a medication primarily used to treat anxiety disorders, particularly generalized anxiety disorder. Benefits support its short term use. It has not been found to be effective in treating psychosis. It is taken by mouth, and it may take up to four weeks for an effect.
North American market for Buspirone is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Buspirone is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Buspirone include Bristol Myers Squibb, Apotex, Dr. Reddy's Laboratories, Laboratoires Servier, Teva, AMAG Pharmaceuticals, Mylan, Novartis, Watson Laboratories, Hikma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Buspirone, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Buspirone.
The Buspirone market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Buspirone market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Buspirone manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Buspirone Market Report

Report Metric Details
Report Name Buspirone Market
Segment by Type
  • 5mg
  • 10mg
  • 15mg
  • 30mg
Segment by Application
  • Hospital
  • Drug Store
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Bristol Myers Squibb, Apotex, Dr. Reddy's Laboratories, Laboratoires Servier, Teva, AMAG Pharmaceuticals, Mylan, Novartis, Watson Laboratories, Hikma, Wockhardt, Cadila Healthcare, Orion Corporation
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Buspirone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Buspirone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Buspirone Market report?

Ans: The main players in the Buspirone Market are Bristol Myers Squibb, Apotex, Dr. Reddy's Laboratories, Laboratoires Servier, Teva, AMAG Pharmaceuticals, Mylan, Novartis, Watson Laboratories, Hikma, Wockhardt, Cadila Healthcare, Orion Corporation

What are the Application segmentation covered in the Buspirone Market report?

Ans: The Applications covered in the Buspirone Market report are Hospital, Drug Store

What are the Type segmentation covered in the Buspirone Market report?

Ans: The Types covered in the Buspirone Market report are 5mg, 10mg, 15mg, 30mg

1 Buspirone Market Overview
1.1 Product Definition
1.2 Buspirone by Type
1.2.1 Global Buspirone Market Value Comparison by Type (2024 VS 2031)
1.2.2 5mg
1.2.3 10mg
1.2.4 15mg
1.2.5 30mg
1.3 Buspirone by Application
1.3.1 Global Buspirone Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Drug Store
1.4 Global Buspirone Market Size Estimates and Forecasts
1.4.1 Global Buspirone Revenue 2020-2031
1.4.2 Global Buspirone Sales 2020-2031
1.4.3 Global Buspirone Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Buspirone Market Competition by Manufacturers
2.1 Global Buspirone Sales Market Share by Manufacturers (2020-2025)
2.2 Global Buspirone Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Buspirone Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Buspirone, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Buspirone, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Buspirone, Product Type & Application
2.7 Global Key Manufacturers of Buspirone, Date of Enter into This Industry
2.8 Global Buspirone Market Competitive Situation and Trends
2.8.1 Global Buspirone Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Buspirone Players Market Share by Revenue
2.8.3 Global Buspirone Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Buspirone Market Scenario by Region
3.1 Global Buspirone Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Buspirone Sales by Region: 2020-2031
3.2.1 Global Buspirone Sales by Region: 2020-2025
3.2.2 Global Buspirone Sales by Region: 2026-2031
3.3 Global Buspirone Revenue by Region: 2020-2031
3.3.1 Global Buspirone Revenue by Region: 2020-2025
3.3.2 Global Buspirone Revenue by Region: 2026-2031
3.4 North America Buspirone Market Facts & Figures by Country
3.4.1 North America Buspirone Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Buspirone Sales by Country (2020-2031)
3.4.3 North America Buspirone Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Buspirone Market Facts & Figures by Country
3.5.1 Europe Buspirone Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Buspirone Sales by Country (2020-2031)
3.5.3 Europe Buspirone Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Buspirone Market Facts & Figures by Region
3.6.1 Asia Pacific Buspirone Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Buspirone Sales by Region (2020-2031)
3.6.3 Asia Pacific Buspirone Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Buspirone Market Facts & Figures by Country
3.7.1 Latin America Buspirone Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Buspirone Sales by Country (2020-2031)
3.7.3 Latin America Buspirone Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Buspirone Market Facts & Figures by Country
3.8.1 Middle East and Africa Buspirone Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Buspirone Sales by Country (2020-2031)
3.8.3 Middle East and Africa Buspirone Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Buspirone Sales by Type (2020-2031)
4.1.1 Global Buspirone Sales by Type (2020-2025)
4.1.2 Global Buspirone Sales by Type (2026-2031)
4.1.3 Global Buspirone Sales Market Share by Type (2020-2031)
4.2 Global Buspirone Revenue by Type (2020-2031)
4.2.1 Global Buspirone Revenue by Type (2020-2025)
4.2.2 Global Buspirone Revenue by Type (2026-2031)
4.2.3 Global Buspirone Revenue Market Share by Type (2020-2031)
4.3 Global Buspirone Price by Type (2020-2031)
5 Segment by Application
5.1 Global Buspirone Sales by Application (2020-2031)
5.1.1 Global Buspirone Sales by Application (2020-2025)
5.1.2 Global Buspirone Sales by Application (2026-2031)
5.1.3 Global Buspirone Sales Market Share by Application (2020-2031)
5.2 Global Buspirone Revenue by Application (2020-2031)
5.2.1 Global Buspirone Revenue by Application (2020-2025)
5.2.2 Global Buspirone Revenue by Application (2026-2031)
5.2.3 Global Buspirone Revenue Market Share by Application (2020-2031)
5.3 Global Buspirone Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Bristol Myers Squibb
6.1.1 Bristol Myers Squibb Company Information
6.1.2 Bristol Myers Squibb Description and Business Overview
6.1.3 Bristol Myers Squibb Buspirone Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Bristol Myers Squibb Buspirone Product Portfolio
6.1.5 Bristol Myers Squibb Recent Developments/Updates
6.2 Apotex
6.2.1 Apotex Company Information
6.2.2 Apotex Description and Business Overview
6.2.3 Apotex Buspirone Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Apotex Buspirone Product Portfolio
6.2.5 Apotex Recent Developments/Updates
6.3 Dr. Reddy's Laboratories
6.3.1 Dr. Reddy's Laboratories Company Information
6.3.2 Dr. Reddy's Laboratories Description and Business Overview
6.3.3 Dr. Reddy's Laboratories Buspirone Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Dr. Reddy's Laboratories Buspirone Product Portfolio
6.3.5 Dr. Reddy's Laboratories Recent Developments/Updates
6.4 Laboratoires Servier
6.4.1 Laboratoires Servier Company Information
6.4.2 Laboratoires Servier Description and Business Overview
6.4.3 Laboratoires Servier Buspirone Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Laboratoires Servier Buspirone Product Portfolio
6.4.5 Laboratoires Servier Recent Developments/Updates
6.5 Teva
6.5.1 Teva Company Information
6.5.2 Teva Description and Business Overview
6.5.3 Teva Buspirone Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Teva Buspirone Product Portfolio
6.5.5 Teva Recent Developments/Updates
6.6 AMAG Pharmaceuticals
6.6.1 AMAG Pharmaceuticals Company Information
6.6.2 AMAG Pharmaceuticals Description and Business Overview
6.6.3 AMAG Pharmaceuticals Buspirone Sales, Revenue and Gross Margin (2020-2025)
6.6.4 AMAG Pharmaceuticals Buspirone Product Portfolio
6.6.5 AMAG Pharmaceuticals Recent Developments/Updates
6.7 Mylan
6.7.1 Mylan Company Information
6.7.2 Mylan Description and Business Overview
6.7.3 Mylan Buspirone Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Mylan Buspirone Product Portfolio
6.7.5 Mylan Recent Developments/Updates
6.8 Novartis
6.8.1 Novartis Company Information
6.8.2 Novartis Description and Business Overview
6.8.3 Novartis Buspirone Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Novartis Buspirone Product Portfolio
6.8.5 Novartis Recent Developments/Updates
6.9 Watson Laboratories
6.9.1 Watson Laboratories Company Information
6.9.2 Watson Laboratories Description and Business Overview
6.9.3 Watson Laboratories Buspirone Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Watson Laboratories Buspirone Product Portfolio
6.9.5 Watson Laboratories Recent Developments/Updates
6.10 Hikma
6.10.1 Hikma Company Information
6.10.2 Hikma Description and Business Overview
6.10.3 Hikma Buspirone Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Hikma Buspirone Product Portfolio
6.10.5 Hikma Recent Developments/Updates
6.11 Wockhardt
6.11.1 Wockhardt Company Information
6.11.2 Wockhardt Description and Business Overview
6.11.3 Wockhardt Buspirone Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Wockhardt Buspirone Product Portfolio
6.11.5 Wockhardt Recent Developments/Updates
6.12 Cadila Healthcare
6.12.1 Cadila Healthcare Company Information
6.12.2 Cadila Healthcare Description and Business Overview
6.12.3 Cadila Healthcare Buspirone Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Cadila Healthcare Buspirone Product Portfolio
6.12.5 Cadila Healthcare Recent Developments/Updates
6.13 Orion Corporation
6.13.1 Orion Corporation Company Information
6.13.2 Orion Corporation Description and Business Overview
6.13.3 Orion Corporation Buspirone Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Orion Corporation Buspirone Product Portfolio
6.13.5 Orion Corporation Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Buspirone Industry Chain Analysis
7.2 Buspirone Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Buspirone Production Mode & Process Analysis
7.4 Buspirone Sales and Marketing
7.4.1 Buspirone Sales Channels
7.4.2 Buspirone Distributors
7.5 Buspirone Customer Analysis
8 Buspirone Market Dynamics
8.1 Buspirone Industry Trends
8.2 Buspirone Market Drivers
8.3 Buspirone Market Challenges
8.4 Buspirone Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Bristol–Myers Squibb
Apotex
Dr. Reddy’s Laboratories
Laboratoires Servier
TEVA
AMAG Pharmaceuticals
Mylan NV
Novartis
Watson Laboratories
Hikma
WOCKHARDT
Cadila Healthcare
Orion Corporation
List of Tables
 Table 1. Global Buspirone Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Buspirone Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Buspirone Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Buspirone Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Buspirone Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Buspirone Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Buspirone Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Buspirone Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Buspirone, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Buspirone, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Buspirone, Product Type & Application
 Table 12. Global Key Manufacturers of Buspirone, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Buspirone by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Buspirone as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Buspirone Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Buspirone Sales by Region (2020-2025) & (K Units)
 Table 18. Global Buspirone Sales Market Share by Region (2020-2025)
 Table 19. Global Buspirone Sales by Region (2026-2031) & (K Units)
 Table 20. Global Buspirone Sales Market Share by Region (2026-2031)
 Table 21. Global Buspirone Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Buspirone Revenue Market Share by Region (2020-2025)
 Table 23. Global Buspirone Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Buspirone Revenue Market Share by Region (2026-2031)
 Table 25. North America Buspirone Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Buspirone Sales by Country (2020-2025) & (K Units)
 Table 27. North America Buspirone Sales by Country (2026-2031) & (K Units)
 Table 28. North America Buspirone Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Buspirone Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Buspirone Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Buspirone Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Buspirone Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Buspirone Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Buspirone Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Buspirone Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Buspirone Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Buspirone Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Buspirone Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Buspirone Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Buspirone Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Buspirone Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Buspirone Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Buspirone Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Buspirone Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Buspirone Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Buspirone Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Buspirone Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Buspirone Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Buspirone Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Buspirone Sales (K Units) by Type (2020-2025)
 Table 51. Global Buspirone Sales (K Units) by Type (2026-2031)
 Table 52. Global Buspirone Sales Market Share by Type (2020-2025)
 Table 53. Global Buspirone Sales Market Share by Type (2026-2031)
 Table 54. Global Buspirone Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Buspirone Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Buspirone Revenue Market Share by Type (2020-2025)
 Table 57. Global Buspirone Revenue Market Share by Type (2026-2031)
 Table 58. Global Buspirone Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Buspirone Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Buspirone Sales (K Units) by Application (2020-2025)
 Table 61. Global Buspirone Sales (K Units) by Application (2026-2031)
 Table 62. Global Buspirone Sales Market Share by Application (2020-2025)
 Table 63. Global Buspirone Sales Market Share by Application (2026-2031)
 Table 64. Global Buspirone Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Buspirone Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Buspirone Revenue Market Share by Application (2020-2025)
 Table 67. Global Buspirone Revenue Market Share by Application (2026-2031)
 Table 68. Global Buspirone Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Buspirone Price (US$/Unit) by Application (2026-2031)
 Table 70. Bristol Myers Squibb Company Information
 Table 71. Bristol Myers Squibb Description and Business Overview
 Table 72. Bristol Myers Squibb Buspirone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Bristol Myers Squibb Buspirone Product
 Table 74. Bristol Myers Squibb Recent Developments/Updates
 Table 75. Apotex Company Information
 Table 76. Apotex Description and Business Overview
 Table 77. Apotex Buspirone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Apotex Buspirone Product
 Table 79. Apotex Recent Developments/Updates
 Table 80. Dr. Reddy's Laboratories Company Information
 Table 81. Dr. Reddy's Laboratories Description and Business Overview
 Table 82. Dr. Reddy's Laboratories Buspirone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Dr. Reddy's Laboratories Buspirone Product
 Table 84. Dr. Reddy's Laboratories Recent Developments/Updates
 Table 85. Laboratoires Servier Company Information
 Table 86. Laboratoires Servier Description and Business Overview
 Table 87. Laboratoires Servier Buspirone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Laboratoires Servier Buspirone Product
 Table 89. Laboratoires Servier Recent Developments/Updates
 Table 90. Teva Company Information
 Table 91. Teva Description and Business Overview
 Table 92. Teva Buspirone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Teva Buspirone Product
 Table 94. Teva Recent Developments/Updates
 Table 95. AMAG Pharmaceuticals Company Information
 Table 96. AMAG Pharmaceuticals Description and Business Overview
 Table 97. AMAG Pharmaceuticals Buspirone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. AMAG Pharmaceuticals Buspirone Product
 Table 99. AMAG Pharmaceuticals Recent Developments/Updates
 Table 100. Mylan Company Information
 Table 101. Mylan Description and Business Overview
 Table 102. Mylan Buspirone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Mylan Buspirone Product
 Table 104. Mylan Recent Developments/Updates
 Table 105. Novartis Company Information
 Table 106. Novartis Description and Business Overview
 Table 107. Novartis Buspirone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Novartis Buspirone Product
 Table 109. Novartis Recent Developments/Updates
 Table 110. Watson Laboratories Company Information
 Table 111. Watson Laboratories Description and Business Overview
 Table 112. Watson Laboratories Buspirone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Watson Laboratories Buspirone Product
 Table 114. Watson Laboratories Recent Developments/Updates
 Table 115. Hikma Company Information
 Table 116. Hikma Description and Business Overview
 Table 117. Hikma Buspirone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Hikma Buspirone Product
 Table 119. Hikma Recent Developments/Updates
 Table 120. Wockhardt Company Information
 Table 121. Wockhardt Description and Business Overview
 Table 122. Wockhardt Buspirone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Wockhardt Buspirone Product
 Table 124. Wockhardt Recent Developments/Updates
 Table 125. Cadila Healthcare Company Information
 Table 126. Cadila Healthcare Description and Business Overview
 Table 127. Cadila Healthcare Buspirone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Cadila Healthcare Buspirone Product
 Table 129. Cadila Healthcare Recent Developments/Updates
 Table 130. Orion Corporation Company Information
 Table 131. Orion Corporation Description and Business Overview
 Table 132. Orion Corporation Buspirone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Orion Corporation Buspirone Product
 Table 134. Orion Corporation Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Buspirone Distributors List
 Table 138. Buspirone Customers List
 Table 139. Buspirone Market Trends
 Table 140. Buspirone Market Drivers
 Table 141. Buspirone Market Challenges
 Table 142. Buspirone Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Buspirone
 Figure 2. Global Buspirone Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Buspirone Market Share by Type: 2024 & 2031
 Figure 4. 5mg Product Picture
 Figure 5. 10mg Product Picture
 Figure 6. 15mg Product Picture
 Figure 7. 30mg Product Picture
 Figure 8. Global Buspirone Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Buspirone Market Share by Application: 2024 & 2031
 Figure 10. Hospital
 Figure 11. Drug Store
 Figure 12. Global Buspirone Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Buspirone Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Buspirone Sales (2020-2031) & (K Units)
 Figure 15. Global Buspirone Average Price (US$/Unit) & (2020-2031)
 Figure 16. Buspirone Report Years Considered
 Figure 17. Buspirone Sales Share by Manufacturers in 2024
 Figure 18. Global Buspirone Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Buspirone Players: Market Share by Revenue in Buspirone in 2024
 Figure 20. Buspirone Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Buspirone Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Buspirone Sales Market Share by Country (2020-2031)
 Figure 23. North America Buspirone Revenue Market Share by Country (2020-2031)
 Figure 24. United States Buspirone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Buspirone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Buspirone Sales Market Share by Country (2020-2031)
 Figure 27. Europe Buspirone Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Buspirone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Buspirone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Buspirone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Buspirone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Buspirone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Buspirone Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Buspirone Revenue Market Share by Region (2020-2031)
 Figure 35. China Buspirone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Buspirone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Buspirone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Buspirone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Buspirone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Buspirone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Buspirone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Buspirone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Buspirone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Buspirone Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Buspirone Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Buspirone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Buspirone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Buspirone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Buspirone Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Buspirone Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Buspirone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Buspirone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Buspirone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Buspirone by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Buspirone by Type (2020-2031)
 Figure 56. Global Buspirone Price (US$/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Buspirone by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Buspirone by Application (2020-2031)
 Figure 59. Global Buspirone Price (US$/Unit) by Application (2020-2031)
 Figure 60. Buspirone Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Global Paroxetine Market Insights Forecast to 2030
Global Anxiolytics Market Research Report 2024
Global Alprazolam Market Insights Forecast to 2030
Global Selective Serotonin Reuptake Inhibitors SSRIs Market Insights Forecast to 2030
Global Mirtazapine Tablets Market Research Report 2024
Global NaSSAs Antidepressants Market Research Report 2024
Global Mebeverine Market Research Report 2024
Anti depressant Drugs Market
Opipramol Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Trifluoperazine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Tiotropium bromide Market Insights Forecast to 2030
Global Amitryptyline Market Insights Forecast to 2030
Global Sertraline Market Insights Forecast to 2030
Stress Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Nortriptyline Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Paliperidone Market Insights Forecast to 2030
Global Pregabalin Market Insights Forecast to 2030
Anti Anxiety Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Aripiprazole Drug Market Insights Forecast to 2030
Depression Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions